• Info
  • Insider Ownership

Insider Trading & Ownership of Julie Jordan

Location
New York, NY
Summary
The estimated net worth of Julie Jordan is at least $277,294 dollars as of 30 Mar 2026. Julie Jordan is the Chief Medical Officer of Neurogene Inc. and owns shares of Neurogene Inc. (NGNE) stock worth about $273.1K. Julie Jordan is the Chief Medical Officer of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $4.2K.
Signature
/s/ Donna M. Cochener, as attorney-in-fact for Julie Jordan
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Julie Jordan and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Julie Jordan has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $277,294.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Neurogene Inc. ($273,051).
  • Past-year value change for that position: -$18,128.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Julie Jordan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NGNE Neurogene Inc. Chief Medical Officer $273,051 -$18,128 -6.2% 26 Mar 2026
QTTB Homology Medicines, Inc. Chief Medical Officer $4,243 03 Aug 2023

Insider Transactions Reported by Julie Jordan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored